Scharnagl H - Search Results

1

Effect of Helicobacter pylori eradication on high-density lipoprotein cholesterol.

Scharnagl H, Kist M, Grawitz AB, Koenig W, Wieland H, März W. Scharnagl H, et al. Am J Cardiol. 2004 Jan 15;93(2):219-20. doi: 10.1016/j.amjcard.2003.09.045. Am J Cardiol. 2004. PMID: 14715353 Clinical Trial.

2

[Fast lipoprotein chromatography: a new method for determining plasma lipoproteins].

März W, Siekmeier R, Scharnagl H, Gross W. März W, et al. Among authors: scharnagl h. Klin Wochenschr. 1990;68 Suppl 22:114-5. Klin Wochenschr. 1990. PMID: 2128355 German.

3

Decreased binding of apolipoprotein (a) to familial defective apolipoprotein B-100 (Arg3500-->Gln). A study of the assembly of recombinant apolipoprotein (a) with mutant low density lipoproteins.

Durovic S, März W, Frank S, Scharnagl H, Baumstark MW, Zechner R, Kostner GM. Durovic S, et al. Among authors: scharnagl h. J Biol Chem. 1994 Dec 2;269(48):30320-5. J Biol Chem. 1994. PMID: 7982944 Free article.

4

Fast lipoprotein chromatography: new method of analysis for plasma lipoproteins.

März W, Siekmeier R, Scharnagl H, Seiffert UB, Gross W. März W, et al. Among authors: scharnagl h. Clin Chem. 1993 Nov;39(11 Pt 1):2276-81. Clin Chem. 1993. PMID: 8222220

5

Accumulation of "small dense" low density lipoproteins (LDL) in a homozygous patients with familial defective apolipoprotein B-100 results from heterogenous interaction of LDL subfractions with the LDL receptor.

März W, Baumstark MW, Scharnagl H, Ruzicka V, Buxbaum S, Herwig J, Pohl T, Russ A, Schaaf L, Berg A, et al. März W, et al. Among authors: scharnagl h. J Clin Invest. 1993 Dec;92(6):2922-33. doi: 10.1172/JCI116915. J Clin Invest. 1993. PMID: 8254047 Free PMC article.

6

Heterogeneous lipoprotein (a) size isoforms differ by their interaction with the low density lipoprotein receptor and the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor.

März W, Beckmann A, Scharnagl H, Siekmeier R, Mondorf U, Held I, Schneider W, Preissner KT, Curtiss LK, Gross W, et al. März W, et al. Among authors: scharnagl h. FEBS Lett. 1993 Jul 5;325(3):271-5. doi: 10.1016/0014-5793(93)81087-g. FEBS Lett. 1993. PMID: 8319809 Free article.

7

The receptor-mediated endocytosis of lipoprotein (a).

März W, Scharnagl H, Mondorf U, Wieland H, Gross W, Kostner GM. März W, et al. Among authors: scharnagl h. Z Gastroenterol. 1996 Jun;34 Suppl 3:131-8. Z Gastroenterol. 1996. PMID: 8767490 No abstract available.

8

Apolipoprotein E5 (Glu212-->Lys): increased binding to cell surface proteoglycans but decreased uptake and lysosomal degradation in cultured fibroblasts.

Feussner G, Scharnagl H, Scherbaum C, Acar J, Dobmeyer J, Lohrmann J, Wieland H, März W. Feussner G, et al. Among authors: scharnagl h. J Lipid Res. 1996 Aug;37(8):1632-45. J Lipid Res. 1996. PMID: 8864947 Free article.

9

Homozygous familial defective apolipoprotein B-100. Enhanced removal of apolipoprotein E-containing VLDLs and decreased production of LDLs.

Schaefer JR, Scharnagl H, Baumstark MW, Schweer H, Zech LA, Seyberth H, Winkler K, Steinmetz A, März W. Schaefer JR, et al. Among authors: scharnagl h. Arterioscler Thromb Vasc Biol. 1997 Feb;17(2):348-53. doi: 10.1161/01.atv.17.2.348. Arterioscler Thromb Vasc Biol. 1997. PMID: 9081691

10

Apolipoprotein E2 (Arg136 --> Cys) mutation in the receptor binding domain of apoE is not associated with dominant type III hyperlipoproteinemia.

März W, Hoffmann MM, Scharnagl H, Fisher E, Chen M, Nauck M, Feussner G, Wieland H. März W, et al. Among authors: scharnagl h. J Lipid Res. 1998 Mar;39(3):658-69. J Lipid Res. 1998. PMID: 9548597 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

296 results

Search Page

Filters